comprehensive -WSS

comprehensive

author：entertainment 2025-10-04 04:01:14 - browse：3715

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Merck, Daiichi strike cancer drug pact worth up to $22 billion

entertainment

WSS

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

STAT Readout Newsletter: Biotech news today

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

AbbVie dramatically boosts its spending on lobbying

Organ transplantation is at a crossroads. Major reform is needed

Our daughter's deadly disease: trisomy 18. We wanted to protect her

leisure time

comprehensive

leisure time

Alkermes shareholders re

Our daughter's deadly disease: trisomy 18. We wanted to protect her

After affirmative action ruling, medical educators look to 'holistic review'

New rules on organ donation and transplantation 'will bring chaos'

Drug repurposing or repositioning? The language matters

ADCs take center stage as promising cancer treatments

Heart attack and stroke risk calculators need revising

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

The cancer drug shortage isn’t new — and neither are the solutions

Results on Novartis prostate cancer therapy could expand its use

Wikipedia

CDC backtracks, saying fully vaccinated people can go maskless indoors

How AI can help patients find reliable information about doctors

Will.i.am, Britney Spears release new single, 'Mind Your Business'

STAT Readout: Friday, Oct. 20 biotech updates

STAT Summit: Meghan O’Rourke on making chronic illness visible

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

hotspot

entertainment

entertainment

knowledge